Nxera Pharma.
company in Tokyo, Japan
- Reports this week
- 0
- Active events
- 0
- Connections
- 22
What's happening
Earlier this month
One to three months ago
-
Eli Lilly received approval for a plant development in Pennsylvania and paid a milestone payment to Nxera Pharma.Some support1 report
-
Market analysis compares the financial performance and outlook of ADC Therapeutics and Nxera Pharma.Some support1 report
-
Nxera Pharma has acquired rights to NBI-’567 through Neurocrine Biosciences, with the goal of improving patient outcomes in Japan.Some support2 reports
Gone quiet
No new reports in 90+ days-
Nxera Pharma is developing and selling biopharmaceutical products in markets including the US, UK, Japan, Switzerland, and Bermuda.Some support1 report
-
A collaboration between AbbVie, Genmab, and Nxera Pharma has seen joint trial success, leading to potential milestone payments and favorable opinions from the European Commission.Some support1 report
-
AbbVie and Nxera Pharma announced a collaboration to discover novel medicines.Some support1 report
-
FDA clearance enabled clinical development for Nxera Pharma, which operates in key locations including Cambridge, Basel, and Seoul.Speculative1 report
-
Eli Lilly and Company, Novo Nordisk, and Nxera Pharma are noted as key players in the alcohol use disorder market.Speculative1 report
-
Nxera Pharma collaborates with Centessa Pharmaceuticals to develop a novel orexin receptor 2 agonist, resulting in milestone payments.Some support1 report
-
Nxera Pharma operates in key locations including Basel, Seoul, and Osaka.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Nxera Pharma this week
News at the entities that move Nxera Pharma most-
Eli Lilly and Company StructuralMajor companies and central banks are meeting this week to discuss earnings reports and future rate outlooks.Moves Nxera Pharma
-
AbbVie OperationalThe FDA approved a Skyrizi regimen for Crohn's disease, based on an AFFIRM trial led by UNC.Moves Nxera Pharma
-
Switzerland Shared contextConflict is causing soaring fuel prices in Switzerland, leading motorists to cross borders for cheaper gas and sparking political debate.Moves Nxera Pharma
-
Bermuda Shared contextThe 44Cup sailing race visited multiple international locations, including Cartagena, Dubai, Bermuda, and Antigua, on October 23, 2026.Moves Nxera Pharma
-
Osaka Shared contextCities in Ho Chi Minh City and Osaka held a conference focused on innovation and cooperation.Moves Nxera Pharma
-
Basel Shared contextSadiq Khan was seen at a factory in Los Angeles while Basel launched a legal cannabis pilot project.Moves Nxera Pharma
Connections
The 12 strongest of 22, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Eli Lilly and Company Structural
A development partnership exists where Eli Lilly's subsidiary provides milestone payments to Nxera Pharma.
-
Neurocrine Biosciences Operational
The companies are engaged in a collaborative partnership to advance the development of the asset NBI-1117567, which originated from a rights acquisition by Nxera from Neurocrine.
-
AbbVie Operational
AbbVie and Nxera Pharma are engaged in a formal collaboration to discover novel medicines, including potential milestone payments.
-
ADC Therapeutics Operational
The companies are actively competing in the market, as evidenced by direct comparisons of their financial and market performance.
-
Osaka Shared context
Nxera Pharma operates within the key locations of Osaka as part of its global footprint.
-
Switzerland Shared context
Nxera Pharma develops and sells biopharmaceutical products within Switzerland.
-
Basel Shared context
Nxera Pharma operates in Basel, utilizing it as a key location for its business activities.
-
Seoul Shared context
Nxera Pharma operates from a key location within the city of Seoul.
Show all 12 connections
-
Bermuda Shared context
Nxera Pharma operates and sells biopharmaceutical products within the jurisdiction of Bermuda.
-
Singapore Shared context
Nxera Pharma operates within the market access context of Singapore.
-
Cambridge Shared context
Nxera Pharma is geographically located in Cambridge, U.K.
-
Southeast Asia Shared context
Nxera Pharma is expanding its specialty business operations within the Southeast Asia region.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
2 eventsAugust 2026
1 eventShow 2 earlier months
July 2026
1 eventJune 2026
6 events- A collaboration between AbbVie, Genmab, and Nxera Pharma has seen joint trial success, leading to potential milestone payments and favorable opinions from the European Commission.
- AbbVie and Nxera Pharma announced a collaboration to discover novel medicines.
- FDA clearance enabled clinical development for Nxera Pharma, which operates in key locations including Cambridge, Basel, and Seoul.
- Eli Lilly and Company, Novo Nordisk, and Nxera Pharma are noted as key players in the alcohol use disorder market.
- Nxera Pharma collaborates with Centessa Pharmaceuticals to develop a novel orexin receptor 2 agonist, resulting in milestone payments.
- Nxera Pharma operates in key locations including Basel, Seoul, and Osaka.